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An effective cardiovascular disease prevention and rehabilitation programme (CPRP) can be defined as follows: 'The delivery of a coordinated sum of activities which favourably influences the underlying cause(s) of cardiovascular disease (CVD), as well as the provision of optimum physical, mental and social conditions to enable patients to take control of their condition, restore function and adopt healthy lifestyle behaviours.' A CPRP is a critical element within the management pathway for most patients with heart disease and has a particularly strong evidence base for individuals with either symptomatic athero-thrombotic vascular disease or heart failure. Following acute myocardial infarction and/or coronary revascularisation, attending and completing a CPRP is associated with an absolute risk reduction in cardiovascular mortality from 10.4% to 7.6% when compared with those who do not, with a number needed to treat (NNT) of 37. In addition, there is a significant reduction in acute hospital admissions (reduced from 30.7% to 26.1%, NNT 22), which is a key determinant of the intervention's very favourable cost-efficacy profile. 1 For individuals with a diagnosis of heart failure, cardiac rehabilitation does not reduce total mortality but does impact favourably on hospitalisation, with a 25% relative risk reduction in overall hospital admissions and a 39% reduction (NNT 18) in acute heart failure related episodes. 2 Given the strength of supportive scientific data it is no surprise that referral to a CPRP receives a Class 1A recommendation within the European Society of Cardiology (ESC) CVD Prevention Guidelines 3 and is a priority 'call to action' in a recent World Health Organization report. 4 However, despite the persuasive evidence-base and the overwhelming cost-efficacy profile the reality remains that it is only a minority of eligible patients that access and complete a programme of CVD prevention and rehabilitation. Comparison of registry data taken from patients with coronary artery disease across multiple European countries (EUROASPIRE IV and EUROASPIRE V) demonstrates an actual fall in total participation from 43% to 34%. The reasons for this dichotomy are complex and only partially understood, but the more obvious factors include deficiencies in process (inefficient identification, referral and call/recall mechanisms); lack of flexibility (Monday-Friday 9 am to 5 pm working, lack of community or home-based offer, non-personalised care pathways); social/cultural obstacles (language barriers, pressures of returning to work) and lack of advocacy amongst senior clinicians and managers. 5 The patient population is also very different today from that of 20 years ago, with advanced age and multimorbidity being the norm and therefore offering a complex, behavioural intervention through a CPRP has become an even greater challenge. Nevertheless, the role of highly skilled, multi-disciplinary professionals working together to deliver an effective CPRP has never been more relevant nor under such intense pressure to succeed. The burden of delivering acute hospital care is rising at an alarming rate and therefore the consequent economic pressures which vex the commissioner/funders of healthcare services must not be allowed to impact upon the quality or availability of CPRPs. In fact, quite the opposite -the promotion, provision and finances of CVD prevention and rehabilitation needs to increase substantially in order to keep pace with international guidelines and deliver the improved outcomes that the scientific evidence predicts. 4 With this in mind, and if the expansion of prevention and rehabilitation services is to be campaigned for and realised, it is essential that existing CPRPs operate at a level commensurate with the evidence-base and that all the core elements of these programmes are being delivered in accordance with agreed standards. Failure to do so may lead funding organisations and even patients themselves to lose confidence in these services and, potentially, result in a negligible impact on important CVD outcome measures. 6 In the issue of the European Journal of Preventive Cardiology, Ö gmundsdottir Michelsen et al. report the Perfect Cardiac Rehabilitation study, 7 an analysis of the structure, function and processes of CPRPs across Sweden. This observational research was conducted via a detailed, Web-based questionnaire and achieved a commendable 100% response rate from all 78 programmes, providing a valuable and unique insight into their alignment with ESC standards. In terms of those factors that might be perceived as critical -hospital initiation, early commencement, core clinical staffing, minimum course duration and lifestyle risk factor interventions -the vast majority of Swedish cardiac rehabilitation services perform at a high level. However, much wider variation was seen across other important programme elements such as medical risk factor management, the delivery of personalised education, multi-disciplinary team (MDT) case review and the provision of written information concerning medical risk factors and individualised goals. Data were also obtained regarding the composition of the MDT and relative patient numbers per member of staff. These demonstrated that relatively few programmes provided the services of occupational therapists and psychologists and that the case load for nurses and physiotherapists varied tremendously across the country. The authors' overall conclusion was that whilst the fundamental composition and structures of most Swedish CPRPs were consistent with ESC recommendations there were some key areas of significant variation and deficiency, including high level medical leadership/ advocacy and comprehensive medical risk factor management.
CPRPs offer an incredibly complex intervention the success of which is dependent upon the co-ordinated delivery of medical, social, behavioural and psychological therapies within a structured framework of effective processes. Only those programmes which consistently achieve the evidence-based portfolio of comprehensive cardiac rehabilitation are likely to deliver the short, medium and long-term clinical outcomes upon which the existence of such programmes are predicated. 8 Understanding the extent of any variation in practice at individual service level should lead to a process of review and redesign and (potentially) to enhanced resource allocation, and this, in turn, may facilitate the strategic development of CPRP accreditation. Such an initiative has been rolled out across the UK over the last three years and whilst the clinical impact of this cannot yet be ascertained, there is no doubt that programmes have become more engaged in the national audit outputs and reflective of their practices. 9, 10 
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